DEVELOPMENT OF A NONSURFACTANT FORMULATION FOR INDUCING AGENTS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 13899
Amount: $318,778.00
Phase: Phase II
Program: SBIR
Awards Year: 1992
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Pharmatec Inc.
Po Box 730, Alachua, FL, 32615
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Wesley R Anderson
 (904) 462-1210
Business Contact
Phone: () -
Research Institution
N/A
Abstract
ADVERSE REACTIONS HAVE BEEN REPORTED TO OCCUR AFTER ADMINISTRATION OF COMPOUNDS SOLUBILIZED IN AQUEOUS VEHICLES. THESE SIDE EFFECTS MAY BE REDUCED OR ELIMINATED BY COMBINING THE PRIMARY INDUCING AGENT, ALFAXALONE, WITH CYCLODEXTRINS, WHICH HAVE BEEN SHOWN TO IMPROVE SOLUBILITY AND EFFICACY OF OTHER STEROIDS. PRELIMINARY STUDIES IN A RAT MODEL SHOW PROMISE FOR THIS COMBINATION. SUCCESSFUL DEVELOPMENT OF THIS TECHNIQUE WILL PROVIDE A SAFE ALTERNATIVE FOR A NONSURFACTANT FORMULATION FOR THE INDUCINGAGENT, REDUCING TOXIC SIDE EFFECTS AND ALLOWING SAFE AND RELIABLE ANESTHESIA.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government